Nucleate ✕ idalab | AI in Biotech
This panel brings together perspectives from a global pharmaceutical company, a clinical-stage biotech, and a venture capital investor. We’ll explore how pharma is integrating AI into large-scale R&D pipelines, how biotech companies are leveraging AI to innovate faster, and what investors look for in AI-driven biotech ventures.
Panelists
- Djork-Arné Clevert, VP & Head of Machine Learning at Pfizer
- Jonathan Montagu, President & CEO at HotSpot Therapeutics
Rabab Nasrallah, Principal at Earlybird Health
Agenda
- 6:00 p.m. - Doors open
- 6:30 p.m. - Panel starts
- 7:30 p.m. - Drinks and networking
Please sign up here.